Mumbai: Homegrown biopharma major Suven Life Sciences on Tuesday reported over 65 per cent increase in its net loss for the fourth quarter (Q4) of FY25, as a significant drop in revenue weighed heavily on its financial performance. The company posted a consolidated net loss of Rs 43.9 crore in Q4, compared to a loss of Rs 26.5 crore in the same quarter last fiscal (Q4 FY24) reflecting a steep year-on-year (YoY) increase of nearly 65.66 per cent, according to its stock exchange filing. Thi
Recommended For You
